Lanoxin Injectie (Digoxin)

Digoxin works by inhibiting the Na⁺/K⁺‑ATPase pump on heart muscle cells, which raises intracellular sodium. This change reduces the Na⁺/Ca²⁺ exchange, leading to higher intracellular calcium levels that strengthen heart contractions. It also increases vagal tone, slowing conduction through the atrioventricular node.

The appropriate dose of Lanoxin Injectie is individualized by the prescribing clinician based on factors such as the patient’s age, renal function, electrolyte status, and severity of the cardiac condition. No fixed regimen is provided here; dosing decisions are made by qualified healthcare professionals.

Digoxin is classified as Pregnancy Category C, meaning risk cannot be ruled out. It may be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited data are available for breastfeeding, so clinicians should evaluate the risk‑benefit ratio before use.

To order Lanoxin Injectie, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Lanoxin Injectie (digoxin) provides a positive inotropic effect and rate control, whereas agents such as milrinone act via phosphodiesterase inhibition and primarily increase contractility without significant AV‑node effects. Digoxin has a narrow therapeutic window and requires careful monitoring, while some newer inotropes may have broader safety margins but different side‑effect profiles.

Lanoxin Injectie should be stored at 2‑8 °C in a refrigerator, protected from light. The vial must not be frozen or shaken vigorously. Keep the product in its original packaging until use to maintain stability and potency.

The medication is given by intravenous injection or infusion under the supervision of a qualified healthcare professional. Dosage and rate of administration are determined by the prescriber, and the solution should be administered using aseptic technique to avoid contamination.

The most critical risks include digoxin toxicity, which can manifest as life‑threatening cardiac arrhythmias, severe bradycardia, heart block, and hyperkalemia. Visual disturbances such as blurred or colored vision may also signal toxicity and require immediate medical evaluation.

Lanoxin Injectie is contraindicated in patients with known hypersensitivity to digoxin or other cardiac glycosides, in those with uncontrolled ventricular arrhythmias, and in individuals with severe renal impairment where drug clearance is markedly reduced. Caution is also advised for patients with electrolyte imbalances such as hypokalemia.